-+ 0.00%
-+ 0.00%
-+ 0.00%

Citigroup Initiates Coverage On Vor Biopharma with Buy Rating, Announces Price Target of $50

Benzinga·01/09/2026 12:48:10
Listen to the news
Citigroup analyst Geoff Meacham initiates coverage on Vor Biopharma (NASDAQ:VOR) with a Buy rating and announces Price Target of $50.